Ncardia 产品代理
Ncardia 产品代理
我们的细胞模型组合包括hiPSC衍生的心血管、神经和免疫细胞。基于这一专业知识，Ncardia为药物发现提供了心血管和神经服务的全面菜单——从疾病建模到药物疗效筛查和心脏安全评估。对于细胞治疗开发人员，我们合作创新iPSC衍生的高级疗法。
Drug Discovery
Cell Therapy
Cell Models
Ncardia is a human iPSC technology company. We operate worldwide with facilities, offices and staff throughout Europe and North America. Ncardia is built on the belief that stem cell technology will help bring better therapies to patients faster. Our goal is to enable biopharmaceutical companies in drug discovery and cell therapy to better integrate human iPSC technologies in their development process.
Our cell model portfolio includes hiPSC-derived cardiovascular, neural and immune cells. Building on this expertise, Ncardia provides a comprehensive menu of cardiovascular and neuronal services for drug discovery - from disease modeling to drug efficacy screening and cardiac safety assessment. For cell therapy developers, we partner to innovate iPSC-derived advanced therapies.
